Identification of a Novel Prognostic Lymphangiogenesis-Related Signature Associated with Tumor Immunity for Guiding Therapy in Lung Adenocarcinoma

<div>The correlation between LUAD-related genes and risk score. (a) The expression of LUAD-related genes in the high- and low-risk groups. (b) The correlation between LUAD-related genes and hub signatures.</div>

Analytical Cellular Pathology

fig13

Figure 13

Figure 13: Identification of a Novel Prognostic Lymphangiogenesis-Related Signature Associated with Tumor Immunity for Guiding Therapy in Lung Adenocarcinoma 

Figure 13 | Identification of a Novel Prognostic Lymphangiogenesis-Related Signature Associated with Tumor Immunity for Guiding Therapy in Lung Adenocarcinoma 